跳至主要内容
临床试验/EUCTR2006-001384-30-GB
EUCTR2006-001384-30-GB进行中(未招募)1 期

Standard vs reduced dose naloxone for the reversal of opiate overdose. Does dose modification increase the likelihood of reaching hospital and entering a substance misuse programme? - Standard vs reduced dose naloxone

Brighton and Sussex Universities Hospitals Trust Research and Development Directorate0 个研究点目标入组 190 人开始时间: 2006年6月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Known or suspected opiate OD AND
  • Age >18 AND
  • Weight >40 kg (estimated) AND
  • Respiratory rate <8 OR airway compromise OR hypoxia (<90%) OR GCS <9
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Tracheal intubation already performed OR
  • Improving neurological status OR
  • Active seizure OR
  • Documented hypoglycaemia OR
  • Other obvious cause for decreased level of consciousness OR
  • Known allergy to naloxone

研究者

发起方
Brighton and Sussex Universities Hospitals Trust Research and Development Directorate

相似试验